# OnCo record dennis-slamon (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/dennis-slamon/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "dennis-slamon" ;
  schema:name "Dennis J. Slamon"@en ;
  schema:description "Linked HER2 amplification to aggressive breast cancer and drove trastuzumab and later palbociclib to approval."@en ;
  schema:url <https://onco.cc/people/dennis-slamon/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Dennis_Slamon> ;
  schema:citation <https://www.uclahealth.org/providers?q=Dennis%20J.%20Slamon>, <https://pubmed.ncbi.nlm.nih.gov/?term=Slamon%20DJ%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Dennis%20J.%20Slamon> ;
  schema:jobTitle "Director, Clinical/Translational Research, UCLA Jonsson Comprehensive Cancer Center; Chief, Division of Hematology-Oncology" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/cdk4-6/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/ribociclib/> ;
  onco:institutions <https://onco.cc/institutions/ucla-jonsson/> ;
  onco:trials <https://onco.cc/trials/natalee/> ;
  schema:affiliation <https://onco.cc/institutions/ucla-jonsson/> .